Saudi Arabia’s Deputy Defense Minister Prince Khalid bin Salman meets Donald Trump in Washington

Saudi Arabia’s Deputy Defense Minister Prince Khalid bin Salman meets Donald Trump in Washington
1 / 4
Saudi Arabia's Deputy Defense Minister Prince Khalid bin Salman met with Donald Trump in Washington on Monday. (Twitter: @kbsalsaud)
Saudi Arabia’s Deputy Defense Minister Prince Khalid bin Salman meets Donald Trump in Washington
2 / 4
Saudi Arabia's Deputy Defense Minister Prince Khalid bin Salman met with Donald Trump in Washington on Monday. (Twitter: @kbsalsaud)
Saudi Arabia’s Deputy Defense Minister Prince Khalid bin Salman meets Donald Trump in Washington
3 / 4
Saudi Arabia's Deputy Defense Minister Prince Khalid bin Salman met with Donald Trump in Washington on Monday. (Twitter: @kbsalsaud)
Saudi Arabia’s Deputy Defense Minister Prince Khalid bin Salman meets Donald Trump in Washington
4 / 4
The prince also met with the UK defense minister Ben Wallace. (Twitter: @kbsalsaud)
Short Url
Updated 09 January 2020

Saudi Arabia’s Deputy Defense Minister Prince Khalid bin Salman meets Donald Trump in Washington

Saudi Arabia’s Deputy Defense Minister Prince Khalid bin Salman meets Donald Trump in Washington
  • The prince also met with the UK defense minister Ben Wallace

WASHINGTON: Saudi Arabia's Deputy Defense Minister Prince Khalid bin Salman met with Donald Trump in Washington on Monday.

He delivered a message from Crown Prince Mohammed bin Salman, and reviewed aspects of bilateral cooperation, including efforts to confront regional and international challenges.

The prince also met with the UK defense minister Ben Wallace, the two discussed the strategic partnership between Saudi Arabia and Britain, the ongoing regional issues and the two countries' mutual efforts in the war against terror.

President Trump tweeted that he had discussed stability in the Middle East as well as oil prices, security and military issues at a White House meeting with Prince Khalid.

 

 

 


Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
Updated 40 min 25 sec ago

Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
  • It will go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority

RIYADH: Preclinical studies on the first Saudi vaccine against COVID-19 have been completed.

Professor of epidemiology Dr. Iman Almansour, who heads the team of researchers working on the vaccine at the Institute for Research and Medical Consultations (IRMC), affiliated with Imam Abdulrahman Bin Faisal University (IAU), confirmed to Arab News on Friday that the studies were complete, and said clinical trials would begin as soon as “the proper approvals” had been given.

She did not specify when that is expected to happen.

The Ministry of Education is financing the team’s project. The team’s research paper has been published in the peer-reviewed journal Pharmaceuticals.

The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen.

Dr. Iman Almansour, professor of epidemiology

According to the published paper, the vaccine has so far proven effective, when used on animals, in eliciting antibodies that will target the virus. “The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen,” Dr. Almansour explained.

Dr. Turki Almugaiteeb, director of Healthcare and Life Sciences at RPD Innovations, which runs the National Vaccine and Biomanufacturing Center, told Arab News: “There is a great focus on the results of medical research because of the pandemic. Research can play a great role in developing a vaccine that can be adopted and further developed in the future. We can say that the Kingdom has a strong infrastructure, which can help produce and manufacture a national vaccine.”

Both Almugaiteeb and Almansour stressed that the experimental vaccine will need to go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority.

Prof. Nasser Al-Aqeeli, the deputy minister of education for research and innovation, said the ministry supported programs at the Kingdom’s universities with more than SR500 million ($133.3 million) in 2020.